180 related articles for article (PubMed ID: 29524829)
1. The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors.
Aupperlee MD; Kariagina A; Zaremba N; Basson MD; Schwartz RC; Haslam SZ
Transl Oncol; 2018 Apr; 11(2):518-527. PubMed ID: 29524829
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques.
Isaksson E; Wang H; Sahlin L; von Schoultz B; Cline JM; von Schoultz E
Breast Cancer Res Treat; 2003 May; 79(2):233-9. PubMed ID: 12825858
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast.
Hofseth LJ; Raafat AM; Osuch JR; Pathak DR; Slomski CA; Haslam SZ
J Clin Endocrinol Metab; 1999 Dec; 84(12):4559-65. PubMed ID: 10599719
[TBL] [Abstract][Full Text] [Related]
4. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues.
Eigeliene N; Härkönen P; Erkkola R
Cell Cycle; 2008 Jan; 7(1):71-80. PubMed ID: 18196959
[TBL] [Abstract][Full Text] [Related]
5. Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.
Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
Horm Cancer; 2013 Dec; 4(6):381-90. PubMed ID: 23996077
[TBL] [Abstract][Full Text] [Related]
6. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
[TBL] [Abstract][Full Text] [Related]
7. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
[TBL] [Abstract][Full Text] [Related]
8. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
9. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
10. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
11. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
12. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
13. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
15. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
16. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells.
Saitoh M; Ohmichi M; Takahashi K; Kawagoe J; Ohta T; Doshida M; Takahashi T; Igarashi H; Mori-Abe A; Du B; Tsutsumi S; Kurachi H
Endocrinology; 2005 Nov; 146(11):4917-25. PubMed ID: 16123159
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model.
Raafat AM; Li S; Bennett JM; Hofseth LJ; Haslam SZ
J Cell Physiol; 2001 Apr; 187(1):81-9. PubMed ID: 11241352
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.
Goyette S; Liang Y; Mafuvadze B; Cook MT; Munir M; Hyder SM
Breast Cancer (Dove Med Press); 2017; 9():347-357. PubMed ID: 28579829
[TBL] [Abstract][Full Text] [Related]
20. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
